ARROWHEAD PHARMACEUTICALS, INC. Other Comprehensive Income (Loss), Net of Tax
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Other Comprehensive Income (Loss), Net of Tax of -$1.77 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-04
- ARROWHEAD PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$1.77M, a 282.73% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$5.94M, a 2449.41% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was $967.00K.
- ARROWHEAD PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-03-31 was $253.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month |
|---|---|---|---|
| 2026-06-30 | -$1.77M 10-Q · filed 2026-08-04 | -$7.71M derived: sum of 2 quarters · filed 2026-08-04 | -$7.45M 10-Q · filed 2026-08-04 |
| 2026-03-31 | -$5.94M 10-Q · filed 2026-05-07 | -$5.69M 10-Q · filed 2026-05-07 | |
| 2025-06-30 | $967.00K 10-Q · filed 2026-08-04 | $1.22M derived: sum of 2 quarters · filed 2026-08-04 | $607.00K 10-Q · filed 2026-08-04 |
| 2025-03-31 | $253.00K 10-Q · filed 2026-05-07 | -$360.00K 10-Q · filed 2026-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |